Alico, Inc. Announces Fiscal Year 2017 Second Quarter Dividend
Feb 27, 2017 21:15 pm UTC| Business
FORT MYERS, Fla., Feb. 27, 2017 -- Alico, Inc. (the “Company”) (NASDAQ:ALCO), a holding company with assets and related operations in agriculture and natural resources, announced that its Board of Directors, on February...
Full House Resorts Announces Fourth Quarter Earnings Release Date
Feb 27, 2017 21:15 pm UTC| Business
LAS VEGAS, Feb. 27, 2017 -- Full House Resorts (NASDAQ:FLL) announced today that it will report its fourth quarter 2016 and full-year financial results after the markets close on Monday, March 6, 2017, followed by a...
AppFolio, Inc. Announces Fourth Quarter and Fiscal Year 2016 Financial Results
Feb 27, 2017 21:15 pm UTC| Business
SANTA BARBARA, Calif., Feb. 27, 2017 -- AppFolio, Inc. (NASDAQ:APPF) ("AppFolio" or the "Company"), a leading provider of cloud-based business software solutions, today announced its financial results for the fourth...
Pilgrim's Pride to Host Annual Meeting of Shareholders on April 28, 2017
Feb 27, 2017 21:15 pm UTC| Business
GREELEY, Colo., Feb. 27, 2017 -- Pilgrim's Pride Corporation (NASDAQ:PPC) will host its annual meeting of shareholders on Friday, April 28, 2017, at 8 a.m. Mountain / 10 a.m. Eastern. This meeting, which will include a...
Feb 27, 2017 21:15 pm UTC| Business
NEW YORK, Feb. 27, 2017 -- Fortress Transportation and Infrastructure Investors LLC (NYSE:FTAI) today announced that Joe Adams, FTAI Chief Executive Officer, will present at the 2017 Raymond James Institutional...
Feb 27, 2017 21:15 pm UTC| Business
TAMPA, Fla., Feb. 27, 2017 -- LM Funding America, Inc. (NASDAQ:LMFA), a specialty finance company offering unique funding solutions to community associations, received a favorable ruling from a Federal District Court...
BeiGene to Present at the Cowen and Company 37th Annual Health Care Conference
Feb 27, 2017 21:15 pm UTC| Business
CAMBRIDGE, Mass., Feb. 27, 2017 -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today...